-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $39

Benzinga·04/21/2025 12:57:41
Listen to the news
HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and raises the price target from $38 to $39.